SERPINE1 and type 2 diabetes mellitus: In particular, different studies demonstrated increased PAI-1 levels in subjects with obesity, metabolic syndrome, and T2DM (Vague et al., 1986; Landin et al., 1990; Juhan-Vague et al., 2003; Bilgili et al., 2008).